Unusual 11 Midday Movers 02/29: (JOEZ) (QUAD) (GEVO) Higher; (VOCS) (OXF) (CNTF) Lower
Tweet
Share
E-mail
Get Alerts VOCS Hot Sheet
Join SI Premium – FREE
Vocus, Inc. (NASDAQ: VOCS) 38.1% LOWER; reported Q4 EPS of $0.24, $0.02 better than the analyst estimate of $0.22. Revenue for the quarter came in at $30.5 million versus the consensus estimate of $30.23 million. Sees Q1 2012 EPS of $-0.01-$0.00. Sees Q1 2012 revenue of $34.7-$35 million. Sees FY2012 EPS of $0.35-$0.37, versus the consensus of $0. Sees FY2012 revenue of $169.9-$171.4 million. The stock was downgraded at Baird and Wunderlich this morning.
Oxford Resource Partners LP (NYSE: OXF) 32% LOWER; reported Q4 EPS of ($0.24), which may not compare to the analyst estimate of $0.13. Revenue for the quarter came in at $96.29 million versus the consensus estimate of $112.84 million.
China TechFaith (NASDAQ: CNTF) 26.5% LOWER; reported Q4 EPS of $0.05, versus $0.17 reported last year. Revenue for the quarter came in at $81.7 million, versus $76.9 million reported last year. TechFaith currently expects total revenue for its ODP, branded and gaming businesses to be in the range of US$41 million to US$45 million in the first quarter of 2012.
Joe's Jean, Inc. (NASDAQ: JOEZ) 21.4% HIGHER; reported Q4 EPS of $0.00, $0.01 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $25.4 million versus the consensus estimate of $23.6 million. Retail same store sales increased 12%.
Gain Capital Holdings, Inc. (NYSE: GCAP) 18.7% LOWER; reported Q4 EPS of ($0.05), versus $0.10 reported last year. Revenue for the quarter came in at $31.6 million, versus $40.9 million reported last year.
Central European Distribution (NASDAQ: CEDC) 18.4% LOWER; reported Q4 EPS of $0.11, $0.22 worse than the analyst estimate of $0.33. Revenue for the quarter came in at $280.1 million versus the consensus estimate of $293.93 million.
Quad/Graphics, Inc. (NYSE: QUAD) 16.9% HIGHER; reported Q4 EPS of $0.19, $0.81 worse than the analyst estimate of $1.00. Revenue for the quarter came in at $1.31 billion versus the consensus estimate of $1.26 billion.
Gevo Inc. (Nasdaq: GEVO) 15.8% HIGHER; revenues for the fourth quarter were $17.2 million compared to $14.1 million in the same period in 2010 and well above the Street’s consensus of $15.82 million. An earnings loss of $0.54 per share was inline with the Street’s expectations, and was substantially higher than the $6.35 per share loss reported last year.
Nektar Therapeutics (Nasdaq: NKTR) 12.7% HIGHER; has agreed to sell to Royalty Pharma its royalties on future sales of CIMZIA®, under Nektar's agreement with UCB Pharma, and MIRCERA®, under Nektar's agreement with Roche. In consideration for the sale, Royalty Pharma will pay Nektar an aggregate cash payment of $124.0 million.
LSB Industries, Inc. (NYSE: LXU) 12.6% HIGHER; reported Q4 EPS of $1.19, $0.33 better than the analyst estimate of $0.86. Revenue for the quarter came in at $215.4 million versus the consensus estimate of $195.15 million.
Cerus Corp (NASDAQ: CERS) 11% HIGHER; reported Q4 EPS of ($0.16), $0.07 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $10.42 million versus the consensus estimate of $8.19 million. The stock was upgraded to Outperform at Baird.
Oxford Resource Partners LP (NYSE: OXF) 32% LOWER; reported Q4 EPS of ($0.24), which may not compare to the analyst estimate of $0.13. Revenue for the quarter came in at $96.29 million versus the consensus estimate of $112.84 million.
China TechFaith (NASDAQ: CNTF) 26.5% LOWER; reported Q4 EPS of $0.05, versus $0.17 reported last year. Revenue for the quarter came in at $81.7 million, versus $76.9 million reported last year. TechFaith currently expects total revenue for its ODP, branded and gaming businesses to be in the range of US$41 million to US$45 million in the first quarter of 2012.
Joe's Jean, Inc. (NASDAQ: JOEZ) 21.4% HIGHER; reported Q4 EPS of $0.00, $0.01 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $25.4 million versus the consensus estimate of $23.6 million. Retail same store sales increased 12%.
Gain Capital Holdings, Inc. (NYSE: GCAP) 18.7% LOWER; reported Q4 EPS of ($0.05), versus $0.10 reported last year. Revenue for the quarter came in at $31.6 million, versus $40.9 million reported last year.
Central European Distribution (NASDAQ: CEDC) 18.4% LOWER; reported Q4 EPS of $0.11, $0.22 worse than the analyst estimate of $0.33. Revenue for the quarter came in at $280.1 million versus the consensus estimate of $293.93 million.
Quad/Graphics, Inc. (NYSE: QUAD) 16.9% HIGHER; reported Q4 EPS of $0.19, $0.81 worse than the analyst estimate of $1.00. Revenue for the quarter came in at $1.31 billion versus the consensus estimate of $1.26 billion.
Gevo Inc. (Nasdaq: GEVO) 15.8% HIGHER; revenues for the fourth quarter were $17.2 million compared to $14.1 million in the same period in 2010 and well above the Street’s consensus of $15.82 million. An earnings loss of $0.54 per share was inline with the Street’s expectations, and was substantially higher than the $6.35 per share loss reported last year.
Nektar Therapeutics (Nasdaq: NKTR) 12.7% HIGHER; has agreed to sell to Royalty Pharma its royalties on future sales of CIMZIA®, under Nektar's agreement with UCB Pharma, and MIRCERA®, under Nektar's agreement with Roche. In consideration for the sale, Royalty Pharma will pay Nektar an aggregate cash payment of $124.0 million.
LSB Industries, Inc. (NYSE: LXU) 12.6% HIGHER; reported Q4 EPS of $1.19, $0.33 better than the analyst estimate of $0.86. Revenue for the quarter came in at $215.4 million versus the consensus estimate of $195.15 million.
Cerus Corp (NASDAQ: CERS) 11% HIGHER; reported Q4 EPS of ($0.16), $0.07 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $10.42 million versus the consensus estimate of $8.19 million. The stock was upgraded to Outperform at Baird.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Comerica (CMA) PT Raised to $54 at Piper Sandler
- Intuitive Surgical (ISRG) PT Raised to $435 at Piper Sandler
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Robert W Baird, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
